Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.01
-0.17 (-1.20%)
At close: Jun 26, 2026, 4:00 PM EDT
14.18
+0.17 (1.21%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $10.87 billion as of June 26, 2026. Its market cap has decreased by -25.22% in one year.
Market Cap
10.87B
Enterprise Value
10.30B
1-Year Change
-25.22%
Ranking
Category
Stock Price
$14.01
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $10.87B, an increase of 9,037.85%. That is a compound annual growth rate of 49.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 10.87B | -16.48% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 13.29B |
| Ionis Pharmaceuticals | 12.65B |
| Axsome Therapeutics | 12.24B |
| Madrigal Pharmaceuticals | 11.75B |
| Arrowhead Pharmaceuticals | 11.24B |
| BioMarin Pharmaceutical | 11.08B |
| Cytokinetics | 11.02B |
| Krystal Biotech | 10.25B |